These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 26965867

  • 1. Design, synthesis and docking studies of novel dipeptidyl boronic acid proteasome inhibitors constructed from αα- and αβ-amino acids.
    Shi J, Lei M, Wu W, Feng H, Wang J, Chen S, Zhu Y, Hu S, Liu Z, Jiang C.
    Bioorg Med Chem Lett; 2016 Apr 15; 26(8):1958-62. PubMed ID: 26965867
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors.
    Ge Y, Li A, Wu J, Feng H, Wang L, Liu H, Xu Y, Xu Q, Zhao L, Li Y.
    Eur J Med Chem; 2017 Mar 10; 128():180-191. PubMed ID: 28182990
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and biological evaluation of curcumin derivatives modified with α-amino boronic acid as proteasome inhibitors.
    Zhang W, Bai H, Han L, Zhang H, Xu B, Cui J, Wang X, Ge Z, Li R.
    Bioorg Med Chem Lett; 2018 Aug 01; 28(14):2459-2464. PubMed ID: 29886021
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, in vitro and in vivo biological evaluation, docking studies, and structure--activity relationship (SAR) discussion of dipeptidyl boronic acid proteasome inhibitors composed of beta-amino acids.
    Zhu Y, Zhu X, Wu G, Ma Y, Li Y, Zhao X, Yuan Y, Yang J, Yu S, Shao F, Li R, Ke Y, Lu A, Liu Z, Zhang L.
    J Med Chem; 2010 Mar 11; 53(5):1990-9. PubMed ID: 20158184
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, in vitro and in vivo evaluation, and structure-activity relationship (SAR) discussion of novel dipeptidyl boronic acid proteasome inhibitors as orally available anti-cancer agents for the treatment of multiple myeloma and mechanism studies.
    Lei M, Feng H, Bai E, Zhou H, Wang J, Shi J, Wang X, Hu S, Liu Z, Zhu Y.
    Bioorg Med Chem; 2018 Aug 07; 26(14):3975-3981. PubMed ID: 29934218
    [Abstract] [Full Text] [Related]

  • 6. Discovery of a novel dipeptidyl boronic acid proteasome inhibitor for the treatment of multiple myeloma and triple-negative breast cancer.
    Lei M, Feng H, Bai E, Zhou H, Wang J, Qin Y, Zhang H, Wang X, Liu Z, Hai O, Liu J, Zhu Y.
    Org Biomol Chem; 2019 Jan 16; 17(3):683-691. PubMed ID: 30601533
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and biological evaluation of peptidyl epoxyketone proteasome inhibitors composed of β-amino acids.
    Zhang J, Han M, Ma X, Xu L, Cao J, Zhou Y, Li J, Liu T, Hu Y.
    Chem Biol Drug Des; 2014 Nov 16; 84(5):497-504. PubMed ID: 24751157
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis and biological evaluation of novel tripeptidyl epoxyketone derivatives constructed from β-amino acid as proteasome inhibitors.
    Zhang J, Cao J, Xu L, Zhou Y, Liu T, Li J, Hu Y.
    Bioorg Med Chem; 2014 Jun 01; 22(11):2955-65. PubMed ID: 24767818
    [Abstract] [Full Text] [Related]

  • 9. 3D-QSAR-aided design, synthesis, in vitro and in vivo evaluation of dipeptidyl boronic acid proteasome inhibitors and mechanism studies.
    Lei M, Feng H, Wang C, Li H, Shi J, Wang J, Liu Z, Chen S, Hu S, Zhu Y.
    Bioorg Med Chem; 2016 Jun 01; 24(11):2576-2588. PubMed ID: 27117691
    [Abstract] [Full Text] [Related]

  • 10. Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors.
    Marastoni M, Trapella C, Scotti A, Fantinati A, Ferretti V, Marzola E, Eleonora G, Gavioli R, Preti D.
    J Enzyme Inhib Med Chem; 2017 Dec 01; 32(1):865-877. PubMed ID: 28657369
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, in vitro and in vivo biological evaluation, and comprehensive understanding of structure-activity relationships of dipeptidyl boronic acid proteasome inhibitors constructed from β-amino acids.
    Zhu Y, Wu G, Zhu X, Ma Y, Zhao X, Li Y, Yuan Y, Yang J, Yu S, Shao F, Lei M.
    J Med Chem; 2010 Dec 23; 53(24):8619-26. PubMed ID: 21077681
    [Abstract] [Full Text] [Related]

  • 12. Novel aromatic sulfonyl naphthalene-based boronates as 20S proteasome inhibitors.
    Liu H, Wu J, Ge Y, Li A, Li J, Liu Z, Xu Y, Xu Q, Li Y.
    Bioorg Med Chem; 2018 Mar 01; 26(5):1050-1061. PubMed ID: 29426629
    [Abstract] [Full Text] [Related]

  • 13. Development of novel selective peptidomimetics containing a boronic acid moiety, targeting the 20S proteasome as anticancer agents.
    Scarbaci K, Troiano V, Ettari R, Pinto A, Micale N, Di Giovanni C, Cerchia C, Schirmeister T, Novellino E, Lavecchia A, Zappalà M, Grasso S.
    ChemMedChem; 2014 Aug 01; 9(8):1801-16. PubMed ID: 24891205
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis, biological evaluation, and structure-activity relationship (SAR) discussion of dipeptidyl boronate proteasome inhibitors, part I: comprehensive understanding of the SAR of alpha-amino acid boronates.
    Zhu Y, Zhao X, Zhu X, Wu G, Li Y, Ma Y, Yuan Y, Yang J, Hu Y, Ai L, Gao Q.
    J Med Chem; 2009 Jul 23; 52(14):4192-9. PubMed ID: 19537716
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological activity of peptide proline-boronic acids as proteasome inhibitors.
    Han L, Wen Y, Li R, Xu B, Ge Z, Wang X, Cheng T, Cui J, Li R.
    Bioorg Med Chem; 2017 Aug 01; 25(15):4031-4044. PubMed ID: 28634039
    [Abstract] [Full Text] [Related]

  • 16. Urea-containing peptide boronic acids as potent proteasome inhibitors.
    Han LQ, Yuan X, Wu XY, Li RD, Xu B, Cheng Q, Liu ZM, Zhou TY, An HY, Wang X, Cheng TM, Ge ZM, Cui JR, Li RT.
    Eur J Med Chem; 2017 Jan 05; 125():925-939. PubMed ID: 27769033
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors.
    Zhang J, Shen L, Wang J, Luo P, Hu Y.
    Med Chem; 2014 Jan 05; 10(1):38-45. PubMed ID: 23676009
    [Abstract] [Full Text] [Related]

  • 18. Immunoproteasome β5i-Selective Dipeptidomimetic Inhibitors.
    Singh PK, Fan H, Jiang X, Shi L, Nathan CF, Lin G.
    ChemMedChem; 2016 Oct 06; 11(19):2127-2131. PubMed ID: 27561172
    [Abstract] [Full Text] [Related]

  • 19. Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors.
    Scotti A, Trapella C, Ferretti V, Gallerani E, Gavioli R, Marastoni M.
    J Enzyme Inhib Med Chem; 2016 Oct 06; 31(3):456-63. PubMed ID: 25942361
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis, and evaluation of cystargolide-based β-lactones as potent proteasome inhibitors.
    Niroula D, Hallada LP, Le Chapelain C, Ganegamage SK, Dotson D, Rogelj S, Groll M, Tello-Aburto R.
    Eur J Med Chem; 2018 Sep 05; 157():962-977. PubMed ID: 30165344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.